Hans Peter Gerber
Company: 3T Bioscionces
Job title: Chief Scientific Officer
Seminars:
Identification of Novel pHLA Targets for Solid Tumor Targeting with ADCs 10:00 am
Discuss the advantages of intracellular targets (pHLAs) versus viral, neoantigens or conventional cell surface antigens Uncover strategies to find the most prevalent and immunogenic pHLA targets in tumors from CPI responders Review the selection of ADCs targeting pHLA targets to avoid off-tumor, on-target toxicities in normal tissuesRead more
day: Day Two
Panel Discussion: Ensuring Your ADC Is Fit For Purpose; Matching the Target Selection to the Property of Your Warhead or Your Linker Drug 2:00 pm
day: Day One